by PEPID Newsroom | Jul 23, 2019 | Alerts
Low-dose aspirin has been recommended and used for decades for prevention of ASCVD. It is well established for SECONDARY prevention of ASCVD, however, recent studies have shown aspirin should not be used for routine PRIMARY prevention of ASCVD due to lack of benefit....
by PEPID Newsroom | Jul 23, 2019 | Alerts
A data analysis of 9 studies from 7 publications totaling to 307, 099 participants with 23,544 cases of incident type 2 diabetes showed a significant inverse association between people who adhered to a plant-based dietary pattern and risk of type 2 diabetes compared...
by PEPID Newsroom | Jul 16, 2019 | Press & Media
– PEPID, the world’s leading provider of specialty medical and nursing software, and Data Soft Logic Corporation, creator of web-based point-of-care software optimized for home health, hospice, and therapy agencies, announced a ten-year renewal of their long-standing partnership. PEPID and Data Soft Logic first started working together in 2011.
by PEPID Newsroom | Jul 11, 2019 | Alerts
New study shows C-reactive protein (CRP) testing in primary care clinics for patients with Chronic Obstructive Pulmonary Disease (COPD) reduces patient reported antibiotic use or receiving antibiotic prescriptions for exacerbation of COPD with no evidence of harm....
by PEPID Newsroom | Jul 10, 2019 | Alerts
According to the NutriNet-Sante prospective cohort study of 101,257 participants with the mean age of 42 and a medium follow-up of 5 years, sugary drinks like soda and fruit juices show a significant association of risk of overall cancer, and breast cancer....
